Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now discovered that CAR...

Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the treatment itself caused any...

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system caused by the immune system. B cells, which are a type of...

When blood cancer cells break through the bone and multiply, tumour cells become dangerously diverse and the immune response in the region changes,...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying a specific gene improves...

Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells. ...

Leukemia is an aggressive blood cancer that disrupts the production of normal blood cells and poses significant challenges for those who face it. For...

An experimental therapy AHA-1031 significantly reduced the size of treatment-resistant lung cancer tumors in animal models by stimulating an immune...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment. However, cancer cells have...

A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children with neuroblastoma, with one...